Clinical Trials Browser

Neoplasm, Residual × N,N-dicyclohexyl-isoborneol-10-sulfonamide × 1 year × Clear all

NCT02458014 2025-09-23

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Phase 2 Completed

Burkitt Lymphoma, Neoplasm, Residual